Rankings
▼
Calendar
IMA FY 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
-49.6% YoY
Gross Profit
-$49M
-311.8% margin
Operating Income
-$71M
-454.0% margin
Net Income
-$69M
-440.3% margin
EPS (Diluted)
$-1.90
Cash Flow
Operating Cash Flow
-$74M
Free Cash Flow
-$76M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$172M
Total Liabilities
$25M
Stockholders' Equity
$147M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$31M
-49.6%
Gross Profit
-$49M
-$16M
-202.1%
Operating Income
-$71M
-$34M
-107.7%
Net Income
-$69M
-$34M
-101.6%
← Q4 2021
All Quarters
Q1 2022 →